Sg3 Management, LLC Gilead Sciences, Inc. Put Options Transaction History

Sg3 Management, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $1.43 Million - $1.62 Million	22,000 Added 73.33%	52,000 $3.78 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.9 Million - $2.08 Million	-30,000 Reduced 50.0%	30,000 $2.07 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $3.6 Million - $4.11 Million	60,000 New	60,000 $3.88 Million
Q3 2017 Jan 25, 2018	SELL	$72.11 - $85.47 $468,715 - $555,555	-6,500 Closed	0 $0
Q2 2017 Feb 26, 2018	BUY	N/A	6,435 Added 9900.0%	6,500 $460,000
Q2 2017 Jan 25, 2018	BUY	N/A	65 New	65 $10,000
Q1 2017 Jan 25, 2018	SELL	N/A	-20,000 Closed	0 $0
Q4 2016 Feb 23, 2018	BUY	N/A	19,800 Added 9900.0%	20,000 $1.43 Million
Q4 2016 Jan 24, 2018	BUY	N/A	200	200 $73,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.